N. Kramkimel

2.7k citations
45 papers · 970 indexed · h-index 15
Topics
Melanoma and MAPK Pathways (17 papers)Cancer Immunotherapy and Biomarkers (15 papers)CAR-T cell therapy research (13 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaNeurology

In The Last Decade

N. Kramkimel

39 papers receiving 948 citations

Peers

N. Kramkimel
Comparison fields: 5 of 72
  • Oncology 638
  • Molecular Biology 241
  • Epidemiology 180
  • Pulmonary and Respiratory Medicine 148
  • Genetics 144
Replace Armando Patrizio with:
Armando Patrizio Italy
Marco Siano Switzerland
Alessandro Inno Italy
Niamh M. Keegan United States
Natalie Prinzi Italy
Monica Valente Italy
Hideaki Fujiwara Japan
Elena Magni Italy
Nicholas A. Kolaitis United States
Ali Manouchehri United States
N. Kramkimel relative to Armando Patrizio Italy Armando Patrizio's profile →
Citations per field
00.5×10×13×
Armando Patrizio · 1×
Citations per year

Countries citing papers authored by N. Kramkimel

Since Specialization
Citations

This map shows the geographic impact of N. Kramkimel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Kramkimel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Kramkimel more than expected).

Fields of papers citing papers by N. Kramkimel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Kramkimel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Kramkimel. The network helps show where N. Kramkimel may publish in the future.

Co-authorship network of co-authors of N. Kramkimel

This figure shows the co-authorship network connecting the top 25 collaborators of N. Kramkimel. A scholar is included among the top collaborators of N. Kramkimel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Kramkimel. N. Kramkimel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 0
4 1
5 3
6 23
7 15
8 11
9 8
10 7
11 0
12 11
13 15
14 5
15 3
16 3
17 1
18 6
19 35
20 27

About N. Kramkimel

N. Kramkimel is a scholar working on Oncology, Dermatology and Molecular Biology, having authored 45 papers that have together received 970 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (17 papers), Cancer Immunotherapy and Biomarkers (15 papers) and CAR-T cell therapy research (13 papers). The work is most often cited by research in Oncology (638 citations), Genetics (144 citations) and Neurology (129 citations). N. Kramkimel has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include N. Dupin, François Goldwasser, Benoı̂t Blanchet, Dimitri Psimaras, Marie‐Françoise Avril, C. Lheure, Michel Vidal, Gaëlle Noé, J. Chanal and Audrey Thomas‐Schoemann. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026